Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
ACP-204
/
Acadia Pharma
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
||||||
||||
ACP-204
/
Acadia Pharma
Enrollment open:
ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study
(clinicaltrials.gov) - May 23, 2024
P3
, N=752, Enrolling by invitation,
Sponsor: ACADIA Pharmaceuticals Inc.
Not yet recruiting --> Enrolling by invitation
||||||||||
ACP-204
/
Acadia Pharma
New P3 trial:
ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study
(clinicaltrials.gov) - Jan 8, 2024
P3
, N=752, Not yet recruiting,
Sponsor: ACADIA Pharmaceuticals Inc.
||||||||||
ACP-204
/
Acadia Pharma
New P2/3 trial:
ACP-204 in Adults With Alzheimer's Disease Psychosis
(clinicaltrials.gov) - Dec 7, 2023
P2/3
, N=1074, Recruiting,
Sponsor: ACADIA Pharmaceuticals Inc.